Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Assembly Biosciences (ASMB) over the last 16 years, with Dec 2024 value amounting to -$51.1 million.

  • Assembly Biosciences' Free Cash Flow rose 0.45% to -$15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.8 million, marking a year-over-year decrease of 344.24%. This contributed to the annual value of -$51.1 million for FY2024, which is 327.43% down from last year.
  • Assembly Biosciences' Free Cash Flow amounted to -$51.1 million in FY2024, which was down 327.43% from $22.5 million recorded in FY2023.
  • Assembly Biosciences' Free Cash Flow's 5-year high stood at $22.5 million during FY2023, with a 5-year trough of -$96.5 million in FY2021.
  • Over the past 3 years, Assembly Biosciences' median Free Cash Flow value was -$51.1 million (recorded in 2024), while the average stood at -$37.7 million.
  • As far as peak fluctuations go, Assembly Biosciences' Free Cash Flow spiked by 126.59% in 2023, and later slumped by 327.43% in 2024.
  • Assembly Biosciences' Free Cash Flow (Yearly) stood at -$63.4 million in 2020, then slumped by 52.13% to -$96.5 million in 2021, then rose by 12.36% to -$84.6 million in 2022, then spiked by 126.59% to $22.5 million in 2023, then slumped by 327.43% to -$51.1 million in 2024.